Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA

被引：0
|
作者：
Amol D Dhamane
Inmaculada Hernandez
Manuela Di Fusco
Cynthia Gutierrez
Mauricio Ferri
Cristina Russ
Wan-Lun Tsai
Birol Emir
Huseyin Yuce
Allison Keshishian
机构：
[1] Bristol Myers Squibb,Department of Pharmacy and Therapeutics, School of Pharmacy
[2] University of Pittsburgh,undefined
[3] Pfizer,undefined
[4] STATinMED Research,undefined
[5] New York City College of Technology,undefined
[6] City University of New York,undefined
来源：
American Journal of Cardiovascular Drugs | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 343
页数：10
相关论文
共 50 条
  • [1] Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
    Dhamane, Amol D.
    Hernandez, Inmaculada
    Di Fusco, Manuela
    Gutierrez, Cynthia
    Ferri, Mauricio
    Russ, Cristina
    Tsai, Wan-Lun
    Emir, Birol
    Yuce, Huseyin
    Keshishian, Allison
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 333 - 343
  • [2] Non-persistence to Oral Anticoagulation Therapy in Elderly Patients with Non-valvular Atrial Fibrillation
    Cao, Yue
    Feng, Yue-Yue
    Du, Wei
    Li, Jing
    Fei, Ya-Lan
    Yang, Hao
    Wang, Meng
    Li, Shi-Jie
    Li, Xian-Jin
    Han, Bing
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 3185 - 3194
  • [3] Persistence to Oral Anticoagulation Treatment in Non-valvular Atrial Fibrillation Patients in the United States
    Dhamane, Amol
    Di Fusco, Manuela
    Gutierrez, Cynthia
    Ferri, Mauricio
    Russ, Cristina
    Tsai, Wan-Lun
    Emir, Birol
    Keshishian, Allison
    [J]. CIRCULATION, 2020, 142
  • [4] NON-PERSISTENCE RISK AND HEALTH CARE RESOURCE UTILIZATION OF ITALIAN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Heiman, F.
    Cataldo, N.
    Cipelli, R.
    Di Virgilio, R.
    De Solda, F.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A602 - A602
  • [5] Effectiveness and safety of oral anticoagulation treatment with acenocoumarol in non-valvular atrial fibrillation
    Castro, Constanza
    Bustos, Luis
    Ocampo, Renato
    Molina, Elda
    Cabrero, Pia
    Vergara, Rene
    Lanas, Fernando
    [J]. REVISTA MEDICA DE CHILE, 2017, 145 (10) : 1243 - 1251
  • [6] Oral anticoagulation in patients with hypertrophic cardiomyopathy and non-valvular atrial fibrillation in Japan
    Kitaoka, Hiroaki
    Carroll, Robert
    Eugene, Natalie
    Teixeira, Bruno Casaes
    Matsuo, Yukako
    Kubo, Toru
    [J]. ESC HEART FAILURE, 2024,
  • [7] New Era of Oral Anticoagulation for Japanese Non-Valvular Atrial Fibrillation Patients
    Hirano, Teruyuki
    [J]. CIRCULATION JOURNAL, 2014, 78 (06) : 1317 - 1319
  • [8] CHANGES OVER TIME IN TREATMENT PERSISTENCE OF ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Lefevre, Cinira
    Johnson, Michelle
    Collings, Shuk-Li
    Evans, David
    Kloss, Sebastian
    Ridha, Essra
    Maguire, Andrew
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 769 - 769
  • [9] Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
    Lindley, Richard, I
    [J]. AUSTRALIAN PRESCRIBER, 2021, 44 (02) : 49 - 52
  • [10] Evaluation of the Level of Anticoagulation Control in Patients with Non-Valvular Atrial Fibrillation
    Zang, Bill
    Setakis, Efrosini
    van Staa, Tjeerd P.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S113 - S114
12345